About
BIOventures
BIOpartners
BIOnews
Contact
Open Menu
Close Menu
About
BIOventures
BIOpartners
BIOnews
Contact
SYNthesis investee organisation Cancer Therapeutics CRC signs 2-year deal with Pfizer
October 26, 2018
SYNthesis investee organisation Cancer Therapeutics CRC signs 2-year deal with Pfizer
SYNthesis med chem acquired by Viva Biotech for USD 80M
